Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1 11Phase NA 5Phase 1/2 4Phase 4 1Phase 3 1

Status

Recruiting 3Completed 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 5Lymphoid 2

Conditions

Prostatic Neoplasms 10Lung Neoplasms 10Breast Neoplasms 8Pancreatic Neoplasms 5Multiple Myeloma 5Brain Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Ovarian Neoplasms 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphatic System Neoplasm 4Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Melanoma 2Inflammatory Breast Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Soft Tissue Neoplasms 1Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Resectable Lung Non-Small Cell Carcinoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Pancreatic Ductal Adenocarcinoma 1Obesity 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × Specimen Handling × Clear all
NCT07609030 2026-05-27

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
90 enrolled
LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT07045727 2026-03-30

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Mayo Clinic

Phase NA Recruiting
20 enrolled
Plasma cell

Multiple Myeloma

NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Mayo Clinic

Phase NA Recruiting
82 enrolled
LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

NCT06559709 2025-09-08

A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant

Fred Hutchinson Cancer Center

Phase NA Completed
26 enrolled
Plasma cell

Multiple Myeloma

NCT03119883 2024-08-09

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Mayo Clinic

Phase NA Completed
35 enrolled
Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡